ANGIOTENSIN CONVERTING ENZYME-INHIBITORS

被引:27
作者
BRECKENRIDGE, A
机构
来源
BMJ-BRITISH MEDICAL JOURNAL | 1988年 / 296卷 / 6622期
关键词
D O I
10.1136/bmj.296.6622.618
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:618 / 620
页数:3
相关论文
共 11 条
[1]   THE EFFECTS OF ANTIHYPERTENSIVE THERAPY ON THE QUALITY-OF-LIFE [J].
CROOG, SH ;
LEVINE, S ;
TESTA, MA ;
BROWN, B ;
BULPITT, CJ ;
JENKINS, CD ;
KLERMAN, GL ;
WILLIAMS, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1657-1664
[2]   HISTORY OF THE DEVELOPMENT OF INHIBITORS OF ANGIOTENSIN-I CONVERSION [J].
FERREIRA, SH .
DRUGS, 1985, 30 :1-5
[3]   CLINICAL-PHARMACOLOGY OF THE ACE INHIBITORS [J].
FYHRQUIST, F .
DRUGS, 1986, 32 :33-39
[4]   ENALAPRIL - A REVIEW OF HUMAN PHARMACOLOGY [J].
GOMEZ, HJ ;
CIRILLO, VJ ;
IRVIN, JD .
DRUGS, 1985, 30 :13-24
[5]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF HYPERTENSION [J].
JOHNSTON, CI ;
ARNOLDA, L ;
HIWATARI, M .
DRUGS, 1984, 27 (03) :271-277
[7]   THE ROLE OF VASODILATOR THERAPY IN THE TREATMENT OF SEVERE CHRONIC HEART-FAILURE [J].
PACKER, M .
DRUGS, 1986, 32 :13-26
[8]   COMPARISON OF CAPTOPRIL AND ENALAPRIL IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE [J].
PACKER, M ;
LEE, WH ;
YUSHAK, M ;
MEDINA, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (14) :847-853
[9]  
SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
[10]   ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE [J].
TODD, PA ;
HEEL, RC .
DRUGS, 1986, 31 (03) :198-248